COVID-19 Omicron Human Challenge Study
Part of Infections, Lungs & breathing clinical trials.
This study is a 'human challenge' trial where healthy volunteers who have been vaccinated and have low antibody levels are deliberately exposed to a newer Omicron variant of COVID-19. The goal is to learn how the virus spreads and how to test treatments or vaccines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old
- You have had at least one COVID-19 vaccine, with the last dose at least 3 months ago
- You have antibodies against SARS-CoV-2 (from a prior infection or vaccine)
- Your antibody levels are low enough that you might still get infected (a blood test will confirm)
- You are generally healthy with no serious medical conditions, and you are a non-smoker
- You are willing to stay in quarantine for the study period and use effective contraception if applicable
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental COVID-19 vaccine to see if it is safe and how well it works against current variants. It is for healthy adults who have had a previous COVID-19 vaccine or infection.
This study looks at how the immune system in the body responds to different COVID-19 virus variants. It may help improve how COVID-19 is diagnosed by comparing people who are currently infected and those who are not.
This trial checks how well antibodies from COVID-19 or monkeypox vaccines or treatments work in adults. It helps researchers understand your protection level.
This trial tests how the dengue virus affects healthy adults who have never been exposed to dengue or similar viruses. You would be given a controlled dose of the virus and closely monitored to help researchers understand the infection and develop better treatments or vaccines.
This study tests how healthy adults respond to being exposed to a flu virus in a controlled setting. You will be closely monitored and may help researchers learn more about flu and potential treatments.
This trial studies how viruses affect the body, and how the immune system responds, in both healthy people and people with weakened immunity. It may include people who currently have a suspected or recent viral infection, close contacts, people around the time of a viral vaccine, and healthy adults used for comparison.
Hear when a new SARS-CoV-2 (COVID-19) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.